BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 35066114)

  • 21. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
    Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracerebroventricular Delivery of Gut-derived Microbial Metabolites in Freely Moving Mice.
    Liou CW; Yao TH; Wu WL
    J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
    Luu M; Monning H; Visekruna A
    Front Immunol; 2020; 11():1225. PubMed ID: 32612610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gut-Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production.
    Ju S; Shin Y; Han S; Kwon J; Choi TG; Kang I; Kim SS
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections.
    Ney LM; Wipplinger M; Grossmann M; Engert N; Wegner VD; Mosig AS
    Open Biol; 2023 Mar; 13(3):230014. PubMed ID: 36977462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
    Sajdel-Sulkowska EM
    Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
    Ohira H; Tsutsui W; Fujioka Y
    J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?
    Stilling RM; van de Wouw M; Clarke G; Stanton C; Dinan TG; Cryan JF
    Neurochem Int; 2016 Oct; 99():110-132. PubMed ID: 27346602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
    Sivaprakasam S; Prasad PD; Singh N
    Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
    Deleu S; Machiels K; Raes J; Verbeke K; Vermeire S
    EBioMedicine; 2021 Apr; 66():103293. PubMed ID: 33813134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
    Huang W; Zhou L; Guo H; Xu Y; Xu Y
    Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular link between dietary fibre, gut microbiota and health.
    Kumar J; Rani K; Datt C
    Mol Biol Rep; 2020 Aug; 47(8):6229-6237. PubMed ID: 32623619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids.
    Fang Z; Chen M; Qian J; Wang C; Zhang J
    Cell Mol Neurobiol; 2023 Mar; 43(2):543-559. PubMed ID: 35347532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiome mediation of animal life histories via metabolites and insulin-like signalling.
    Warne RW; Dallas J
    Biol Rev Camb Philos Soc; 2022 Jun; 97(3):1118-1130. PubMed ID: 35043537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of short-chain fatty acid production by gut microbiota in neurodegenerative disorders.
    Yadav S; Dwivedi A; Tripathi A; Tripathi AK
    Nutr Res; 2022 Oct; 106():72-84. PubMed ID: 36152586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut bacterial metabolites of indigestible polysaccharides in intestinal fermentation as mediators of public health.
    Hijova E
    Bratisl Lek Listy; 2019; 120(11):807-812. PubMed ID: 31747759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of microbiota-derived short-chain fatty acids on host and pathogen.
    Mirzaei R; Dehkhodaie E; Bouzari B; Rahimi M; Gholestani A; Hosseini-Fard SR; Keyvani H; Teimoori A; Karampoor S
    Biomed Pharmacother; 2022 Jan; 145():112352. PubMed ID: 34840032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
    Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
    Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological Role of Gut Microbiota for Maintaining Human Health.
    Andoh A
    Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.